Medherant announces positive Phase 1 results of clinical trial of testosterone patch for women
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
Subscribe To Our Newsletter & Stay Updated